MMP9 and ADAM8 (a disintegrin and metalloprotease) co-regulation has been demonstrated to promote breast cancer BM, with ADAM8 reported to upregulate MMP9 and the shedding of P-selectin glycoprotein ligand (PSGL-1) from breast cancer cells. Here, ADAM8 is linked to breast cancer.